Thornburg Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-866
| Closed | -$499K | – | 191 |
|
|
2023
Q1 | $499K | Sell |
866
-299
| -26% | -$169K | 0.01% | 180 |
|
|
2022
Q4 | $642K | Hold |
1,165
| – | – | 0.01% | 179 |
|
|
2022
Q3 | $591K | Hold |
1,165
| – | – | 0.01% | 185 |
|
|
2022
Q2 | $633K | Sell |
1,165
-316
| -21% | -$174K | 0.01% | 185 |
|
|
2022
Q1 | $875K | Buy |
+1,481
| New | +$851K | 0.01% | 177 |
|
|
2021
Q1 | – | Sell |
-25,613
| Closed | -$11.9M | – | 242 |
|
|
2020
Q4 | $11.9M | Sell |
25,613
-120,508
| -82% | -$56.5M | 0.14% | 129 |
|
|
2020
Q3 | $64.5M | Sell |
146,121
-60,854
| -29% | -$25.1M | 0.85% | 36 |
|
|
2020
Q2 | $75M | Sell |
206,975
-63,345
| -23% | -$21.2M | 0.96% | 29 |
|
|
2020
Q1 | $76.7M | Sell |
270,320
-9,404
| -3% | -$2.97M | 1.1% | 23 |
|
|
2019
Q4 | $90.9M | Sell |
279,724
-24,957
| -8% | -$7.57M | 0.87% | 31 |
|
|
2019
Q3 | $88.7M | Buy |
304,681
+13
| +0% | +$3.72K | 0.86% | 34 |
|
|
2019
Q2 | $89.5M | Sell |
304,668
-40,409
| -12% | -$11.1M | 0.86% | 33 |
|
|
2019
Q1 | $94.5M | Buy |
345,077
+17,672
| +5% | +$4.4M | 0.91% | 32 |
|
|
2018
Q4 | $73.3M | Sell |
327,405
-16,839
| -5% | -$3.95M | 0.72% | 38 |
|
|
2018
Q3 | $84M | Sell |
344,244
-43,863
| -11% | -$10.1M | 0.7% | 41 |
|
|
2018
Q2 | $80.4M | Sell |
388,107
-12,024
| -3% | -$2.55M | 0.61% | 45 |
|
|
2018
Q1 | $82.6M | Sell |
400,131
-32,984
| -8% | -$6.92M | 0.62% | 42 |
|
|
2017
Q4 | $82.2M | Buy |
433,115
+17,775
| +4% | +$3.41M | 0.57% | 54 |
|
|
2017
Q3 | $78.6M | Sell |
415,340
-5,491
| -1% | -$994K | 0.56% | 54 |
|
|
2017
Q2 | $73.4M | Sell |
420,831
-2,709
| -0.6% | -$455K | 0.56% | 57 |
|
|
2017
Q1 | $65.1M | Sell |
423,540
-42,173
| -9% | -$6.45M | 0.53% | 53 |
|
|
2016
Q4 | $65.7M | Buy |
465,713
+2,369
| +0.5% | +$349K | 0.51% | 55 |
|
|
2016
Q3 | $73.7M | Sell |
463,344
-6,301
| -1% | -$971K | 0.56% | 51 |
|
|
2016
Q2 | $69.4M | Sell |
469,645
-6,916
| -1% | -$1.02M | 0.54% | 49 |
|
|
2016
Q1 | $67.5M | Sell |
476,561
-924
| -0.2% | -$124K | 0.45% | 60 |
|
|
2015
Q4 | $67.7M | Sell |
477,485
-59,991
| -11% | -$8M | 0.43% | 66 |
|
|
2015
Q3 | $65.7M | Sell |
537,476
-36,853
| -6% | -$4.8M | 0.41% | 64 |
|
|
2015
Q2 | $74.5M | Sell |
574,329
-2,953
| -0.5% | -$385K | 0.43% | 60 |
|
|
2015
Q1 | $77.6M | Sell |
577,282
-4,302
| -0.7% | -$555K | 0.43% | 63 |
|
|
2014
Q4 | $72.9M | Buy |
581,584
+79,347
| +16% | +$9.65M | 0.36% | 75 |
|
|
2014
Q3 | $61.1M | Buy |
502,237
+2,391
| +0.5% | +$291K | 0.28% | 111 |
|
|
2014
Q2 | $59M | Buy |
499,846
+41,487
| +9% | +$4.88M | 0.24% | 126 |
|
|
2014
Q1 | $55.1M | Sell |
458,359
-153,064
| -25% | -$18.2M | 0.22% | 127 |
|
|
2013
Q4 | $68.1M | Sell |
611,423
-16,631
| -3% | -$1.65M | 0.26% | 111 |
|
|
2013
Q3 | $57.9M | Sell |
628,054
-50,981
| -8% | -$4.61M | 0.23% | 114 |
|
|
2013
Q2 | $57.5M | Buy |
+679,035
| New | +$56.5M | 0.26% | 106 |
|
Other funds holding TMO
Thornburg Investment Management's TMO Position: Q2 2023 in Review
Thornburg Investment Management sold out of Thermo Fisher Scientific (TMO) in Q2 2023, closing a stake of 866 shares — an estimated $499K sold.
Thornburg Investment Management first reported a position in TMO in Q2 2013 and held it in 36 quarters. The position peaked at $94.5M in Q1 2019. 2,389 funds tracked by Wall St. Rank hold TMO as of Q2 2023.
- Thornburg Investment Management reported no remaining Thermo Fisher Scientific position as of Q2 2023 after selling out during the quarter.
- Thornburg Investment Management sold 866 Thermo Fisher Scientific shares in Q2 2023, an estimated $499K.
- Thornburg Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 36 quarters.
- Thornburg Investment Management's Thermo Fisher Scientific position peaked at $94.5M in Q1 2019.
- 2,389 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.
Based on Thornburg Investment Management's 13F filing for Q2 2023, filed 8 Aug 2023.